Fortress Biotech, Inc. (FBIO)
NASDAQ·Healthcare·Biotechnology
$2.35
-4.29%
Mkt Cap $90.85M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
Implied Upside
+113.2%
Consensus $5.00 vs current $2.35
NASDAQ·Healthcare·Biotechnology
$2.35
-4.29%
Mkt Cap $90.85M
No recent rating data.
Price Target (1 analysts)
$5.00
Range $5.00 – $5.00
+113.2%
Consensus $5.00 vs current $2.35